These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 27553087)

  • 21. Long-term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients.
    Angelison L; Almer S; Eriksson A; Karling P; Fagerberg U; Halfvarson J; Thörn M; Björk J; Hindorf U; Löfberg R; Bajor A; Hjortswang H; Hammarlund P; Grip O; Torp J; Marsal J; Hertervig E;
    Aliment Pharmacol Ther; 2017 Feb; 45(4):519-532. PubMed ID: 28025840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical and medical treatment in patients with acute severe ulcerative colitis.
    Fornaro R; Caratto M; Barbruni G; Fornaro F; Salerno A; Giovinazzo D; Sticchi C; Caratto E
    J Dig Dis; 2015 Oct; 16(10):558-67. PubMed ID: 26315728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study).
    García MJ; Riestra S; Amiot A; Julsgaard M; García de la Filia I; Calafat M; Aguas M; de la Peña L; Roig C; Caballol B; Casanova MJ; Farkas K; Boysen T; Bujanda L; Cuarán C; Dobru D; Fousekis F; Gargallo-Puyuelo CJ; Savarino E; Calvet X; Huguet JM; Kupcinskas L; López-Cardona J; Raine T; van Oostrom J; Gisbert JP; Chaparro M
    Aliment Pharmacol Ther; 2024 May; 59(10):1248-1259. PubMed ID: 38445785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of acute severe ulcerative colitis.
    Van Assche G; Vermeire S; Rutgeerts P
    Gut; 2011 Jan; 60(1):130-3. PubMed ID: 21030524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative Colitis.
    Taxonera C; Barreiro-de Acosta M; Calvo M; Saro C; Bastida G; Martín-Arranz MD; Gisbert JP; García-Sánchez V; Marín-Jiménez I; Bermejo F; Chaparro M; Ponferrada Á; Martínez-Montiel MP; Pajares R; de Gracia C; Olivares D; Alba C; Mendoza JL; Fernández-Blanco I
    Dig Dis Sci; 2015 Oct; 60(10):3075-84. PubMed ID: 26044830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Managing paediatric acute severe ulcerative colitis according to the 2011 ECCO-ESPGHAN guidelines: Efficacy of infliximab as a rescue therapy.
    Aloi M; D'Arcangelo G; Capponi M; Nuti F; Vassallo F; Civitelli F; Oliva S; Pagliaro G; Cucchiara S
    Dig Liver Dis; 2015 Jun; 47(6):455-9. PubMed ID: 25733340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of outcomes of cyclosporine A and infliximab for steroid-refractory acute severe ulcerative colitis.
    Song EM; Oh EH; Hwang SW; Park SH; Yang DH; Byeon JS; Myung SJ; Yang SK; Ye BD
    J Gastroenterol Hepatol; 2021 Sep; 36(9):2463-2470. PubMed ID: 33783045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ciclosporin Therapy After Infliximab Failure in Hospitalized Patients With Acute Severe Colitis is Effective and Safe.
    Weisshof R; Ollech JE; El Jurdi K; Yvellez OV; Cohen RD; Sakuraba A; Dalal S; Pekow J; Rubin DT
    J Crohns Colitis; 2019 Sep; 13(9):1105-1110. PubMed ID: 30726894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Length of hospital stay and associated hospital costs with infliximab versus cyclosporine in severe ulcerative colitis.
    Löwenberg M; Duijvis NW; Ponsioen C; van den Brink GR; Fockens P; D'Haens GR
    Eur J Gastroenterol Hepatol; 2014 Nov; 26(11):1240-6. PubMed ID: 25171024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural history of first episode of acute severe colitis.
    Ramakrishna BS; Choudhuri G; Kochhar R
    Trop Gastroenterol; 2014 Aug; 35 Suppl 1():S9-11. PubMed ID: 25735120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis.
    Lees CW; Heys D; Ho GT; Noble CL; Shand AG; Mowat C; Boulton-Jones R; Williams A; Church N; Satsangi J; Arnott ID;
    Aliment Pharmacol Ther; 2007 Aug; 26(3):411-9. PubMed ID: 17635376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Similar Short- and Long-term Colectomy Rates with Ciclosporin and Infliximab Treatment in Hospitalised Ulcerative Colitis Patients.
    Duijvis NW; Ten Hove AS; Ponsioen CI; van den Brink GR; Buskens CJ; Bemelman WA; Te Velde AA; D'Haens GR; Löwenberg M
    J Crohns Colitis; 2016 Jul; 10(7):821-7. PubMed ID: 26818660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short- and Long-Term Outcomes of Acute Severe Ulcerative Colitis in Korea: The 1999-2005 Cohort.
    Lee HS; Yang SK; Soh JS; Lee S; Bae JH; Lee HJ; Park SH; Yang DH; Kim KJ; Ye BD; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH
    Inflamm Bowel Dis; 2015 Aug; 21(8):1825-31. PubMed ID: 25985248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infliximab in ulcerative colitis: real-life analysis of factors predicting treatment discontinuation due to lack of response or colectomy: ECIA (ACAD Colitis and Infliximab Study).
    Fernández-Salazar L; Muñoz F; Barrio J; Muñoz C; Pajares R; Rivero M; Prieto V; Legido J; Bouhmidi A; Herranz M; Fernández N; Sánchez-Ocaña R; Joao D; Santos F
    Scand J Gastroenterol; 2016; 51(2):186-95. PubMed ID: 26200929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcome after admission for acute severe ulcerative colitis in Oxford: the 1992-1993 cohort.
    Bojic D; Radojicic Z; Nedeljkovic-Protic M; Al-Ali M; Jewell DP; Travis SP
    Inflamm Bowel Dis; 2009 Jun; 15(6):823-8. PubMed ID: 19145641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-Term Outcome of Patients with Ulcerative Colitis and Primary Non-response to Infliximab.
    Papamichael K; Rivals-Lerebours O; Billiet T; Vande Casteele N; Gils A; Ferrante M; Van Assche G; Rutgeerts PJ; Mantzaris GJ; Peyrin-Biroulet L; Vermeire S
    J Crohns Colitis; 2016 Sep; 10(9):1015-23. PubMed ID: 27022161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting the Course of Disease in Hospitalized Patients With Acute Severe Ulcerative Colitis.
    Bernardo S; Fernandes SR; Gonçalves AR; Valente A; Baldaia C; Santos PM; Correia LA
    Inflamm Bowel Dis; 2019 Feb; 25(3):541-546. PubMed ID: 30085135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcome in patients with ulcerative colitis treated with intravenous cyclosporine A is determined by previous exposure to thiopurines.
    Walch A; Meshkat M; Vogelsang H; Novacek G; Dejaco C; Angelberger S; Mikulits A; Miehsler W; Gangl A; Reinisch W
    J Crohns Colitis; 2010 Oct; 4(4):398-404. PubMed ID: 21122535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infliximab versus cyclosporine as rescue therapy in acute severe steroid-refractory ulcerative colitis: a systematic review and meta-analysis.
    Chang KH; Burke JP; Coffey JC
    Int J Colorectal Dis; 2013 Mar; 28(3):287-93. PubMed ID: 23114475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of a conservative approach in severe ulcerative colitis.
    Daperno M; Sostegni R; Scaglione N; Ercole E; Rigazio C; Rocca R; Pera A
    Dig Liver Dis; 2004 Jan; 36(1):21-8. PubMed ID: 14971812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.